VHIO: Working together to advance personalized and targeted therapies against cancer

JOAQU͍N ARRIBAS

JOAQU͍N ARRIBAS
Director
Biosketch


VHIO´s Preclinical Research Program follows the bench-bedside-bench principle, adopting a purely translational and multidisciplinary approach. At molecular level, we develop xenograft models with explant tumors from patients in mice in order to both mimic the patient´s disease and study tumor development in optimized research models. In so doing,  we accelerate the detection of mutations and mechanisms of resistance to current therapies – ultimately contributing to better outcomes for our patients.